BridgeBio Oncology Therapeutics, Inc. (BBOT): 8-K filed Sep 8, 2026

Form type
8-K
Filing date
Sep 8, 2026
Accession number
0001193125-26-385225
Filer
BridgeBio Oncology Therapeutics, Inc. (CIK 1869105)